Biotech Values

[ghmm]

There is something perversely satisfying about
the notion that hedge funds may be paying big
money to subscribe to a site like this in return
for information that may be bogus.

I agree. In recent years with conference calls and analysts meetings being more readily available to "common" shareholders the playing field is getting a little more level... But some companies don't allow shareholders to ask questions and give 1-1 interviews and other preferential treatment to the bigger players.